obsolete_meningioma: ['A tumor of meningothelial cells that are manifested in the central nervous system and arise from the arachnoid "cap" cells of the arachnoid villi in the meninges.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
3739 |
4. Check minimum number of eventsNone |
3739 |
5. Include endpoints |
3841 |
6. Filter based on genotype QC (FinnGen only) |
3841 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasma benignum meningum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of meninges
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of meninges
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 24691 | 18210 | 6316 |
| Only index persons | 21257 | 16014 | 5243 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.43 | 0.52 | 0.18 |
| Only index persons | 0.49 | 0.59 | 0.20 |
| Median age at first event (years) | |||
| Whole population | 64.58 | 64.77 | 64.01 |
| Only index persons | 63.92 | 64.05 | 63.52 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3841 | 2886 | 955 |
| Unadjusted period prevalence (%) | 0.84 | 0.98 | 0.42 |
| Median age at first event (years) | 62.61 | 61.52 | 65.92 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3394
- Matched controls
- 33940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
2251.8
323.0
376
*
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
+∞
323.0
536
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
20.1
323.0
1444
1207
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
+∞
323.0
1041
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
+∞
323.0
507
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
422.8
323.0
1238
46
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
16384.0
323.0
1849
*
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
1424.5
323.0
855
8
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
+∞
302.7
286
*
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
1260.6
243.6
235
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
40.0
238.2
303
83
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
14.1
230.0
409
327
AA1AD
NOMESCO Finland
CT of head and brain
3.4
208.1
1358
5561
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
198.9
189
*
D32.05
ICD-10 Finland
Cerebral meninges
+∞
193.6
184
*
N03AX14
ATC
levetiracetam; systemic
12.8
186.3
345
298
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.4
185.7
474
725
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.2
182.0
635
1448
D32.03
ICD-10 Finland
Benign meningioma in ventricles
1684.7
161.7
156
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
100.7
148.5
163
17
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.3
146.2
879
3219
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
+∞
141.6
135
*
H02AB02
ATC
dexamethasone; systemic
3.8
140.3
695
2176
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
+∞
129.0
123
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
11.0
126.4
250
243
ZXC95
NOMESCO Finland
Use of surgical navigator
16.6
122.5
201
128
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
121.6
116
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.5
115.8
224
208
N03AF02
ATC
oxcarbazepine; oral
7.6
115.0
283
400
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
29.3
101.2
138
49
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
+∞
100.5
96
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
9.3
93.5
202
230
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
8.9
85.1
188
222
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
84.9
1123
6176
9537/0-C70.0
ICD-O-3
Transitional meningioma of cerebral meninges
+∞
80.5
77
*
2152
FHL
Extraction, big brain
126.0
80.3
86
7
XCK00
NOMESCO Finland
Perimetry
3.5
80.0
418
1321
H53.4
ICD-10 Finland
Visual field defects
7.4
79.2
197
281
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
+∞
77.4
74
*
WX882
NOMESCO Finland
High dependency care
6.6
74.4
200
318
R51.80
ICD-10 Finland
Headache
2.6
71.4
625
2758
N03AB02
ATC
phenytoin; systemic
10.7
68.1
135
131
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.6
65.9
202
380
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
+∞
64.8
62
*
D32
ICD-10 Finland
Benign neoplasm of meninges
+∞
64.8
62
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
49.8
64.6
78
16
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.1
63.1
210
434
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
9.5
61.3
129
140
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
60.6
58
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.6
59.3
159
252
9532/0-C70.0
ICD-O-3
Fibrous meningioma of cerebral meninges
+∞
58.5
56
*
N03AF01
ATC
carbamazepine; oral, rectal
3.6
57.6
281
833
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
54.3
679
3521
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
54.0
829
4687
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
16.5
51.8
84
52
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.4
51.8
199
477
N75
ICPC
Benign neoplasm nervous system
179.4
51.0
53
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
10.2
50.0
101
102
XA800
NOMESCO Finland
Neuropsychological investigation
4.2
49.0
197
493
ZXC40
NOMESCO Finland
Use of ultrasound
11.1
48.2
93
86
D33.30
ICD-10 Finland
Acoustic neuroma
12.3
45.8
84
70
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
10.2
44.8
90
90
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
17.4
44.2
70
41
H47.2
ICD-10 Finland
Optic atrophy
18.0
44.1
69
39
WX110
NOMESCO Finland
Local anesthesy
1.7
43.5
2228
18072
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.8
42.2
92
107
AAK00
NOMESCO Finland
Cranioplasty
47.0
42.0
51
11
A02BC02
ATC
pantoprazole; systemic
1.7
41.6
2269
18597
N02BE01
ATC
paracetamol; systemic, rectal
2.0
40.6
2962
26416
WX402
NOMESCO Finland
General anaesthesia
2.0
39.9
592
3251
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
10.0
39.9
81
83
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.3
39.8
209
654
ZX050
NOMESCO Finland
Stereotactic radiotherapy
12.4
39.6
72
59
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
39.6
463
2301
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
58.2
39.3
46
8
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
65.1
39.1
45
7
N76
ICPC
Neoplasm nervous system unspecified
36.2
39.1
50
14
R42
ICD-10 Finland
Dizziness and giddiness
1.8
39.0
842
5275
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
63.6
38.1
44
7
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.3
38.0
382
1769
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
8.7
37.8
83
98
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
21.5
37.4
55
26
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
36.1
337
1504
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
361.0
36.0
36
*
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
186.9
35.8
37
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.2
35.5
71
71
G40.10
ICD-10 Finland
Simple partial seizures
9.4
35.5
74
80
R4110
NOMESCO Finland
Physiotherapy
1.7
33.7
935
6274
N03AG01
ATC
valproic acid; systemic, rectal
2.7
33.5
241
929
H02AB09
ATC
hydrocortisone; systemic
4.4
33.3
124
289
8000/0-C70.0
ICD-O-3
Neoplasm, benign of cerebral meninges
330.2
32.9
33
*
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
117.8
32.7
35
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
37.7
32.4
41
11
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
8.3
32.4
73
90
WF002
NOMESCO Finland
Radical radiotherapy
3.0
31.7
189
647
TAB00
NOMESCO Finland
Lumbar puncture
3.0
30.8
190
666
H53.2
ICD-10 Finland
Diplopia
3.6
30.8
144
412
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
31.1
30.3
40
13
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
13.9
30.3
52
38
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
14.6
29.2
49
34
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
32.0
29.0
38
12
CS494
NOMESCO Finland
Other visual field testing
3.8
28.6
125
338
WF099
NOMESCO Finland
Other radiotherapy
9.2
28.6
60
66
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.7
27.7
60
70
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
8.0
27.1
62
79
WX872
NOMESCO Finland
Intensive care
2.8
27.1
188
708
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
26.2
495
2926
N03AX18
ATC
lacosamide; systemic
9.8
26.2
53
55
S18
ICPC
Laceration/cut
1.5
25.5
1386
10773
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
7.8
25.5
59
77
101
Kela drug reimbursment
Anterior pituitary hypofunction
12.0
24.7
45
38
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.3
24.2
244
1125
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
24.1
471
2810
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.0
23.9
326
1712
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
23.6
778
5375
183
Kela drug reimbursment
Lamotrigin and topiramate
6.9
23.5
59
87
SPAT1153
SPAT
Removal of sutures
1.5
23.3
1096
8211
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
33.6
23.3
30
9
H47.1
ICD-10 Finland
Papilloedema, unspecified
10.1
23.2
46
46
E23.00
ICD-10 Finland
Panhypopituitarism
11.4
23.1
43
38
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
7.6
22.6
53
71
9537/0-C70.9
ICD-O-3
Transitional meningioma of meninges, NOS
+∞
21.9
21
*
9531/0-C70.9
ICD-O-3
Meningothelial meningioma of meninges, NOS
+∞
21.9
21
*
D33.43
ICD-10 Finland
Spinal cord
115.8
21.6
23
*
9539/1-C70.9
ICD-O-3
Atypical meningioma of meninges, NOS
+∞
20.8
20
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.2
20.8
79
190
9560/0-C72.0
ICD-O-3
Schwannoma, NOS, of spinal cord
77.3
20.7
23
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
13.6
20.5
35
26
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
41.9
20.4
25
6
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
22.5
20.4
29
13
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
20.3
357
2052
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
20.2
1397
11216
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
8.1
20.2
45
56
2254A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal meninges
+∞
19.8
19
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
19.7
525
3414
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.0
19.7
114
385
N03AX16
ATC
pregabalin; oral
1.5
19.6
785
5642
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
19.4
220
1070
N06AX11
ATC
mirtazapine; oral
1.4
19.1
1009
7675
N05CF01
ATC
zopiclone; oral
1.4
19.0
1083
8359
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
55.3
18.9
22
*
L28
ICPC
Limited function/disability (L)
1.6
18.7
550
3669
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
18.5
653
4549
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
44.2
18.2
22
5
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
52.8
17.9
21
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
17.6
243
1282
2312
FHL
Extirpation or destruction
95.5
17.6
19
*
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
95.5
17.6
19
*
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
180.9
17.5
18
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
17.4
174
800
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
7.0
17.1
42
61
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
9.3
17.1
35
38
N01
ICPC
Headache
1.9
17.1
270
1495
N03AX12
ATC
gabapentin; oral
1.6
17.1
508
3393
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.1
17.1
46
76
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
31.6
17.0
22
7
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
13.3
16.9
29
22
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
13.3
16.9
29
22
G44.2
ICD-10 Finland
Tension-type headache
1.6
16.9
424
2708
H93.1
ICD-10 Finland
Tinnitus
2.0
16.7
213
1089
R4120
NOMESCO Finland
Occupational therapy
2.0
16.6
208
1055
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
11.6
16.5
30
26
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.5
16.3
77
225
R4150
NOMESCO Finland
Neuropsychological rehabilitation
6.7
16.3
41
62
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
7.6
16.1
37
49
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
60.3
15.8
18
*
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
15.7
292
1706
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
4.5
15.5
54
121
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
15.4
1423
11820
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.0
15.4
90
308
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
8.7
15.2
32
37
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
20.1
15.1
22
11
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
11.8
15.0
27
23
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
2.3
15.0
138
612
R53
ICD-10 Finland
Malaise and fatigue
1.5
14.8
641
4649
N74
ICPC
Malignant neoplasm nervous system
31.8
14.8
19
6
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
+∞
14.6
14
*
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
80.4
14.6
16
*
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
80.4
14.6
16
*
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.5
14.6
116
476
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
8.9
14.4
30
34
ZXA05
NOMESCO Finland
Left side
1.4
14.3
838
6433
G91.1
ICD-10 Finland
Obstructive hydrocephalus
7.7
14.1
32
42
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
14.1
201
1074
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.2
14.1
73
231
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.2
14.0
52
124
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
14.0
1172
9541
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
14.5
14.0
23
16
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
3.8
14.0
58
153
WX704
NOMESCO Finland
Intubation
1.9
14.0
221
1223
N05BA01
ATC
diazepam; systemic, rectal
1.6
13.9
421
2813
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
13.7
227
1276
N18
ICPC
Paralysis/weakness
3.1
13.7
74
241
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.7
13.5
93
354
2151
FHL
Resection, big brain
34.2
13.5
17
5
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
13.5
315
1971
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.9
13.5
192
1025
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
13.4
306
1901
AAK10
NOMESCO Finland
Repair of dura
18.3
13.4
20
11
ZXA00
NOMESCO Finland
Right side
1.4
13.1
872
6829
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
13.0
648
4814
N03AX11
ATC
topiramate; oral
2.8
13.0
85
312
XKD00
NOMESCO Finland
Uroflowmetry
1.6
12.8
367
2420
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
12.8
526
3759
R51
ICD-10 Finland
Headache
2.0
12.8
154
772
G40.89
ICD-10 Finland
Other epilepsy
8.5
12.7
27
32
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.8
12.7
79
282
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.5
12.7
58
167
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
12.7
111
481
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
70.1
12.6
14
*
ZXC86
NOMESCO Finland
Use of endoscopic device
6.2
12.5
33
54
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.6
12.5
91
358
N28
ICPC
Limited function/disability (N)
3.4
12.5
59
175
M03BX01
ATC
baclofen; systemic
3.3
12.3
62
193
R13
ICD-10 Finland
Dysphagia
1.8
12.2
212
1211
A02BC05
ATC
esomeprazole; systemic
1.3
12.2
1278
10698
H53.1
ICD-10 Finland
Subjective visual disturbances
1.8
12.2
195
1086
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.8
12.1
79
290
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
3.7
11.8
50
136
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
11.7
908
7263
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
30.1
11.6
15
5
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
23.0
11.6
16
7
WX002
NOMESCO Finland
Sedation and analgesia
1.4
11.5
616
4629
G82.2
ICD-10 Finland
Paraplegia, unspecified
6.5
11.5
29
45
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
11.5
348
2324
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
9.3
11.5
23
25
9532/0-C70.9
ICD-O-3
Fibrous meningioma of meninges, NOS
+∞
11.5
11
*
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.6
11.4
83
325
UKC02
NOMESCO Finland
Cystoscopy
1.5
11.4
446
3151
G91.0
ICD-10 Finland
Communicating hydrocephalus
6.7
11.4
28
42
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
11.4
960
7769
A28
ICPC
Limited function/disability NOS
1.5
11.4
481
3454
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.4
11.4
40
92
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
6.3
11.4
29
46
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
11.3
279
1772
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
11.3
296
1909
S06.0
ICD-10 Finland
Concussion
1.6
11.3
288
1843
ZXA10
NOMESCO Finland
Bilateral
1.4
11.2
589
4409
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
17.1
11.2
17
10
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.6
11.1
49
138
AA1AA
NOMESCO Finland
Head X-ray examination
4.5
11.1
38
85
H02AB06
ATC
prednisolone; systemic
1.3
11.1
1423
12199
A02BC01
ATC
omeprazole; systemic
1.3
11.1
854
6816
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
11.0
181
1019
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.3
11.0
96
417
2159
FHL
Other measure in this category
43.4
10.9
13
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
10.9
317
2098
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
10.6
10.8
20
19
N03AX09
ATC
lamotrigine; oral
2.1
10.7
120
584
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
21.5
10.7
15
7
H05.2
ICD-10 Finland
Exophthalmic conditions
7.5
10.6
24
32
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
60.2
10.6
12
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
60.2
10.6
12
*
H46
ICD-10 Finland
Optic neuritis
4.5
10.5
36
81
R4130
NOMESCO Finland
Speech therapy
2.6
10.5
72
276
102
Kela drug reimbursment
Diabetes insipidus
10.0
10.5
20
20
G51.0
ICD-10 Finland
Bell palsy
2.5
10.5
82
338
G992, D321
ICD-10 Finland
NA
+∞
10.4
10
*
9533/0-C70.0
ICD-O-3
Psammomatous meningioma of cerebral meninges
+∞
10.4
10
*
D42.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Meninges, unspecified
32.6
10.3
13
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
23.4
10.2
14
6
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
10.2
911
7413
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.3
10.1
91
403
P20
ICPC
Memory disturbance
1.5
10.0
389
2741
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
40.2
10.0
12
*
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
40.2
10.0
12
*
N80
ICPC
Head injury other
2.9
9.9
57
196
K07.60
ICD-10 Finland
Snapping jaw
1.9
9.8
133
700
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
8.1
9.8
21
26
G47.3
ICD-10 Finland
Sleep apnoea
1.4
9.8
539
4062
N06AX16
ATC
venlafaxine; oral
1.5
9.8
369
2587
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
9.7
291
1941
N04BC06
ATC
cabergoline; oral (dopamine agonists)
7.4
9.7
22
30
N06AX26
ATC
vortioxetine; oral
1.9
9.7
140
756
N06AX21
ATC
duloxetine; oral
1.5
9.7
311
2107
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.5
9.7
308
2082
K91
ICPC
Cerebrovascular disease
3.1
9.6
50
161
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
9.6
243
1552
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
3.4
9.6
45
135
N06AB10
ATC
escitalopram; oral
1.4
9.5
511
3833
N05BA09
ATC
clobazam; oral
6.0
9.5
25
42
N29
ICPC
Neurological sympt/complt other
2.5
9.4
71
286
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
9.4
1864
16722
A02BA02
ATC
ranitidine; systemic
1.4
9.4
614
4758
Q85.1
ICD-10 Finland
Tuberous sclerosis
100.3
9.4
10
*
H50.2
ICD-10 Finland
Vertical strabismus
4.3
9.4
33
77
T32.0
ICD-10 Finland
Corrosions involving less than 10% of body surface
+∞
9.4
9
*
R11
ICD-10 Finland
Nausea and vomiting
1.6
9.4
231
1468
SPAT1216
SPAT
Assessment of functional ability
1.4
9.3
480
3573
N02AX02
ATC
tramadol; systemic, rectal
1.3
9.3
1253
10736
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
9.3
470
3490
A02BC03
ATC
lansoprazole; oral
1.3
9.2
913
7518
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
13.7
9.2
15
11
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.0
9.1
115
590
N88
ICPC
Epilepsy
4.9
9.1
28
57
AAF00
NOMESCO Finland
Ventriculostomy
4.6
9.1
30
66
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
8.3
9.1
19
23
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
2.4
9.0
72
300
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
7.0
9.0
21
30
G40
ICD-10 Finland
Epilepsy
3.8
9.0
36
95
N17
ICPC
Vertigo/dizziness
1.5
9.0
341
2393
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
18.6
8.9
13
7
AA1CF
NOMESCO Finland
Extensive MRI examination of brain with median intensity magnet
24.1
8.9
12
5
WX892
NOMESCO Finland
Monitored bed care
1.6
8.9
205
1280
SPAT1053
SPAT
Memory test
1.4
8.9
477
3575
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.3
8.8
980
8181
H54.4
ICD-10 Finland
Blindness, monocular
6.8
8.8
21
31
J01DB01
ATC
cefalexin; oral
1.3
8.8
2517
23489
N99
ICPC
Neurological disease other
3.2
8.8
43
134
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
8.7
293
2002
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.9
8.7
128
693
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
7.2
8.7
20
28
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
6.9
8.5
20
29
E23.2
ICD-10 Finland
Diabetes insipidus
9.0
8.5
17
19
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.9
8.5
118
629
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
8.4
1124
9585
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.6
8.4
202
1274
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
90.3
8.4
9
*
D33.15
ICD-10 Finland
Another benign tumor of the cerebellum
+∞
8.3
8
*
9537/0-C70.1
ICD-O-3
Transitional meningioma of spinal meninges
+∞
8.3
8
*
9531/0-C70.1
ICD-O-3
Meningothelial meningioma of spinal meninges
+∞
8.3
8
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
8.3
324
2287
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.6
8.3
27
59
R55
ICD-10 Finland
Syncope and collapse
1.5
8.2
301
2099
SPAT1043
SPAT
Audiometry
1.5
8.2
313
2202
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
8.1
287
1985
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
33.4
8.1
10
*
NA7FT
NOMESCO Finland
Labeling lesion in spinal area with X-ray guidance
17.2
8.1
12
7
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
11.7
8.1
14
12
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
8.1
1024
8671
C08CA01
ATC
amlodipine; oral
1.3
8.0
1092
9323
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
8.0
1324
11552
N06AB04
ATC
citalopram; systemic
1.3
8.0
639
5096
ZZF00
NOMESCO Finland
Graft of adipose tissue
3.6
7.9
34
96
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
4.7
7.9
25
53
K90
ICPC
Stroke/cerebrovascular accident
2.1
7.8
83
398
G35
ICD-10 Finland
Multiple sclerosis
2.8
7.8
48
175
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
10.8
7.8
14
13
N03AX15
ATC
zonisamide; oral
10.8
7.8
14
13
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
9.4
7.8
15
16
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
7.8
151
900
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.1
7.8
82
392
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
7.7
127
716
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
7.7
596
4728
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
45.1
7.7
9
*
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
45.1
7.7
9
*
UDC00
NOMESCO Finland
Ear microscopy
1.6
7.7
199
1279
E22.1
ICD-10 Finland
Hyperprolactinaemia
4.2
7.7
27
64
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.7
1001
8495
N05BA04
ATC
oxazepam; oral
1.3
7.7
716
5829
G41.2
ICD-10 Finland
Complex partial status epilepticus
18.4
7.6
11
6
CE2W4
NOMESCO Finland
Eye movement mapping
6.7
7.6
18
27
PA7BD
NOMESCO Finland
CT angiography of neck and brain
2.5
7.5
56
227
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.4
768
6333
G93.0
ICD-10 Finland
Cerebral cysts
4.8
7.4
23
48
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
80.3
7.4
8
*
D42.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal meninges
80.3
7.4
8
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
7.4
386
2878
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
7.4
185
1183
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
7.6
7.4
16
21
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
7.4
75
355
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
7.3
993
8459
8000/0-C70.9
ICD-O-3
Neoplasm, benign of meninges, NOS
+∞
7.3
7
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
3.4
7.3
33
98
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
10.9
7.3
13
12
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
10.9
7.3
13
12
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
7.3
1113
9606
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
7.2
1761
15947
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.1
7.2
81
399
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
7.2
94
491
N07CA01
ATC
betahistine; oral
1.5
7.2
227
1531
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
7.2
476
3685
M54.5
ICD-10 Finland
Low back pain
1.3
7.2
921
7786
AA6AD
NOMESCO Finland
Cranial bones CT examination
30.1
7.1
9
*
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.5
7.1
54
222
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
6.0
7.1
18
30
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
3.6
7.1
30
85
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
8.8
7.0
14
16
R06AE07
ATC
cetirizine; oral
1.2
7.0
1248
10934
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
7.0
262
1832
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
7.0
505
3959
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
7.0
334
2450
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.8
7.0
115
651
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
3.1
7.0
35
113
SPAT1301
SPAT
No procedures
1.2
6.9
933
7930
N03AE01
ATC
clonazepam; systemic
1.6
6.8
163
1029
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
8.3
6.8
14
17
G04CA02
ATC
tamsulosin; oral
1.4
6.8
408
3113
H57.1
ICD-10 Finland
Ocular pain
2.0
6.8
86
445
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
6.8
164
1040
AAD00
NOMESCO Finland
Evacuation of epidural haematoma
40.1
6.8
8
*
H01AC01
ATC
somatropin; parenteral
16.7
6.7
10
6
WZA90
NOMESCO Finland
Other doctors statement
1.3
6.7
593
4784
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
1.5
6.7
202
1350
R35
ICD-10 Finland
Polyuria
1.6
6.7
154
966
AAK99
NOMESCO Finland
Other operation on skull or dura
22.5
6.7
9
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
22.5
6.7
9
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.5
6.7
203
1361
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
6.7
847
7145
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
6.7
116
670
UJF32
NOMESCO Finland
Coloscopy
1.3
6.6
766
6391
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
6.6
609
4939
S09.9
ICD-10 Finland
Unspecified injury of head
2.9
6.6
38
132
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
12.3
6.6
11
9
L01
ICPC
Neck symptom/complaint
1.4
6.5
368
2780
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
6.5
361
2718
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.0
6.5
80
412
AAF15
NOMESCO Finland
Ventriculoatrial shunt
6.2
6.5
16
26
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.0
6.5
77
389
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
6.4
441
3431
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
70.0
6.4
7
*
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
70.0
6.4
7
*
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
70.0
6.4
7
*
B01AB05
ATC
enoxaparin; parenteral
1.2
6.4
910
7771
Z71.8
ICD-10 Finland
Other specified counselling
1.3
6.4
612
4988
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
14.3
6.4
10
7
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
6.4
763
6387
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
6.4
174
1137
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
6.4
281
2032
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
6.3
104
592
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
6.3
127
769
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
6.3
777
6528
22540
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal meninges
+∞
6.2
6
*
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
6.2
6
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
6.2
211
1447
D33.11
ICD-10 Finland
Brain stem
26.7
6.2
8
*
ZZR50
NOMESCO Finland
Mucoperiosteal flap
26.7
6.2
8
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
6.2
319
2373
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
6.2
163
1058
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.2
1306
11603
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
6.3
6.2
15
24
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.1
1406
12584
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
4.2
6.1
21
50
R50.9
ICD-10 Finland
Fever, unspecified
1.4
6.1
342
2578
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.5
6.1
192
1300
21899
ICD-8 Finland
Uterine fibroma
1.6
6.1
160
1036
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.9
6.1
35
123
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
2.1
6.0
63
304
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
10.0
6.0
11
11
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
6.0
287
2105
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
403
179
25.04
307.65
1.6
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
970
3773
3.10
182.39
5.6
7.0
mmol/l
1.0
1.2
0.91
702
2952
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
968
3793
3.08
179.36
5.7
7.0
kpa
5.0
5.1
5.88
935
3609
(3027801) Oxygen [Partial pressure] in Arterial blood
967
3791
3.07
178.98
5.7
7.0
kpa
16.3
12.2
55.63
933
3605
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
582
1675
3.92
175.72
5.1
8.7
mmol/l
24.1
24.4
1.78
567
1552
(3013826) Glucose [Moles/volume] in Serum or Plasma
2684
19468
2.26
113.28
5.6
4.5
mmol/l
6.6
6.7
1.59
2580
18227
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2482
17512
2.18
111.39
7.6
6.4
mmol/l
1.2
1.2
6.12
2161
14676
(3044290) Cell count panel - Cerebral spinal fluid
263
599
4.64
106.94
1.6
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2297
15873
2.11
106.89
6.6
5.7
mmol/l
1.2
1.2
8.51
2115
14225
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
176
300
6.10
99.04
1.9
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
172
307
5.82
92.25
1.8
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
959
5015
2.22
89.80
2.1
2.0
s
28.9
29.8
3.72
926
4865
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
103
108
9.77
88.28
2.3
2.2
umol/l
51.7
52.0
0.02
85
81
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1619
10414
1.96
85.41
2.3
2.1
u/l
157.5
187.8
1.44
1533
9704
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
251
655
4.03
85.17
1.6
1.3
e6/l
69.6
24.7
0.99
193
493
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
251
657
4.02
84.81
1.7
1.4
e6/l
1545.8
1228.2
0.22
197
527
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
114
149
7.85
82.07
2.0
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1359
8388
1.96
79.58
3.8
3.7
%
93.6
90.7
4.18
1317
8156
(3044640) Blood type and Crossmatch panel - Blood
1608
10669
1.87
74.21
2.4
2.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
253
747
3.56
71.63
1.4
1.3
mg/l
706.4
537.9
2.77
239
706
(3032080) INR in Blood by Coagulation assay
1924
13610
1.83
71.29
8.0
9.4
inr
1.2
1.3
2.35
496
3815
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
232
659
3.68
69.58
1.3
1.2
mmol/l
3.6
3.8
1.11
207
615
(3036481) Cortisol [Moles/volume] in Serum or Plasma
624
3017
2.28
68.91
2.8
2.1
nmol/l
368.9
374.1
0.23
579
2740
(4035726)
641
3154
2.24
67.76
1.4
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
624
3120
2.19
63.06
7.2
7.8
g/l
121.4
119.5
1.93
607
3000
(3016502) Oxygen saturation in Arterial blood
654
3354
2.14
61.87
7.0
7.4
%
96.9
95.7
5.97
640
3229
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2060
15393
1.73
58.66
4.0
4.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
455
2051
2.38
58.58
7.0
8.3
%
0.7
0.7
1.43
455
2038
(40768804) Tissue Pathology biopsy report
1899
13892
1.73
58.25
2.4
2.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1248
8140
1.79
57.18
2.3
2.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
454
2067
2.36
57.08
7.0
8.2
%
1.3
1.3
1.64
454
2054
(3023410) Appearance of Cerebral spinal fluid
134
293
4.70
57.03
1.9
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
452
2066
2.35
56.28
7.0
8.4
%
95.2
94.0
5.31
452
2056
(3021387) Prolactin [Units/volume] in Serum or Plasma
203
657
3.21
49.47
2.7
1.6
mu/l
408.2
304.3
2.53
194
596
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
105
219
4.90
47.29
1.5
1.3
mmol/l
2.5
2.1
1.32
90
204
(3014576) Chloride [Moles/volume] in Serum or Plasma
669
4099
1.77
35.52
6.3
6.4
mmol/l
104.8
104.3
2.08
657
4012
(3019060) Gas panel - Arterial blood
418
2205
2.01
35.44
5.8
5.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
58
92
6.39
35.02
2.6
2.2
ug/l
0.7
1.3
1.80
58
85
(3008152) Bicarbonate [Moles/volume] in Arterial blood
396
2108
1.98
32.61
8.8
7.2
mmol/l
24.9
24.7
0.59
381
1951
(3031040) Bacteria [#/volume] in Urine by Automated count
2604
22214
1.53
32.13
5.7
4.9
e6/l
694.3
2042.2
1.68
33
303
(3043409) Potassium [Moles/volume] in Arterial blood
228
1014
2.33
29.78
5.1
4.1
mmol/l
3.8
3.8
1.68
222
955
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
58
115
5.11
27.76
3.1
2.8
umol/l
28.9
29.2
0.04
49
82
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2118
17613
1.45
27.33
6.1
6.1
umol/l
10.6
11.1
1.08
1994
16645
(3013707) Erythrocyte sedimentation rate by Westergren method
2805
24640
1.51
27.31
4.6
4.3
mm/h
12.9
13.4
1.00
2608
22634
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3466
32064
1.83
26.92
19.3
15.0
mg/l
21.5
23.5
3.51
3033
25542
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2899
25691
1.52
26.62
4.9
4.3
pmol/l
14.9
14.9
0.11
2646
23176
(3037467) Urinalysis macro (dipstick) panel - Urine
2620
22746
1.48
26.61
5.4
4.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
462
2802
1.74
24.81
5.8
6.8
mmol/l
8.1
10.0
7.11
434
2667
(3018405) Lactate [Moles/volume] in Arterial blood
242
1188
2.11
24.76
4.9
3.9
mmol/l
1.2
1.4
2.21
242
1167
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3289
30130
1.64
24.70
5.9
5.2
mu/l
3.0
2.1
0.57
3021
27362
(3001604) Monocytes [#/volume] in Blood
1942
16076
1.42
24.54
5.9
5.7
e9/l
0.6
0.6
0.28
1668
13730
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1617
12961
1.43
24.46
4.1
3.8
ng/l
39.4
85.7
0.72
1171
9136
(3006315) Basophils [#/volume] in Blood
1948
16142
1.42
24.43
5.9
5.7
e9/l
0.0
0.0
0.17
1680
13806
(3018418) pH of Serum or Plasma
1354
10519
1.44
24.25
4.5
3.9
ph
7.4
7.4
0.72
230
1953
(3009466) Valproate [Moles/volume] in Serum or Plasma
116
413
2.87
23.97
3.7
5.2
umol/l
348.9
361.9
0.54
109
358
(3019550) Sodium [Moles/volume] in Serum or Plasma
3566
33460
1.92
23.95
23.0
17.4
mmol/l
139.6
139.7
0.41
3519
32612
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2894
25827
1.49
23.91
8.3
7.6
u/l
78.3
79.1
0.44
2730
24151
(3020891) Body temperature
263
1351
2.02
23.80
5.3
4.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1283
9902
1.44
23.66
3.5
3.2
e6/l
47.9
74.5
1.18
1007
7533
(3023103) Potassium [Moles/volume] in Serum or Plasma
3571
33540
1.92
23.64
22.9
17.5
mmol/l
4.0
4.0
2.35
3519
32642
(3026008) Bacteria identified in Urine by Culture
1450
11464
1.43
23.35
3.7
3.4
—
—
—
0
0
(3026782) Osmolality of Urine
900
6506
1.50
23.12
3.1
2.7
mosm/kgh2o
524.6
526.6
0.11
785
5502
(3019198) Lymphocytes [#/volume] in Blood
1973
16482
1.41
23.07
6.0
5.8
e9/l
1.9
1.9
0.16
1724
14363
(3012095) Magnesium [Moles/volume] in Serum or Plasma
780
5487
1.53
22.76
2.7
3.1
mmol/l
0.8
0.8
3.54
716
5071
(42870588) Differential panel, method unspecified - Blood
1407
11106
1.42
22.68
5.9
5.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1198
9185
1.44
22.68
3.4
3.1
e6/l
0.4
0.5
0.41
931
6913
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
905
6573
1.49
22.65
4.0
3.8
ng/l
154.2
452.4
1.29
690
5245
(3013115) Eosinophils [#/volume] in Blood
1993
16716
1.40
22.54
6.2
5.9
e9/l
0.2
0.2
2.48
1736
14524
(3018095) Leukocytes [#/volume] in Urine
1461
11646
1.41
22.12
4.0
3.7
e6/l
70.3
118.4
2.88
1075
8156
(3024561) Albumin [Mass/volume] in Serum or Plasma
1810
14966
1.40
22.11
4.9
4.5
g/l
35.1
35.2
0.54
1673
13806
(3022096) Basophils/100 leukocytes in Blood
1779
14671
1.40
22.05
6.2
6.0
%
0.7
0.7
0.52
1650
13582
(3019069) Monocytes/100 leukocytes in Blood
1829
15159
1.39
21.98
6.5
6.2
%
8.5
8.6
0.77
1703
14086
(3023368) Bacteria identified in Blood by Culture
1175
9032
1.43
21.73
4.7
4.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1818
15080
1.39
21.60
6.2
5.9
%
2.7
2.8
2.05
1685
13950
(3013650) Neutrophils [#/volume] in Blood by Automated count
2211
18951
1.39
21.53
9.3
9.1
e9/l
4.1
4.1
0.51
1945
16496
(3002030) Lymphocytes/100 leukocytes in Blood
1855
15506
1.38
20.68
6.4
6.1
%
27.5
27.7
0.34
1719
14317
(3019309) Folate [Moles/volume] in Red Blood Cells
912
6750
1.46
20.43
1.8
1.8
nmol/l
1103.5
1183.9
1.85
669
5030
(3009214) Lutropin [Units/volume] in Serum or Plasma
123
496
2.53
19.97
1.6
1.3
u/l
11.8
14.6
1.13
98
393
(3018010) Neutrophils/100 leukocytes in Blood
1825
15281
1.37
19.80
6.1
5.8
%
57.8
57.4
0.77
1698
14172
(3003458) Phosphate [Moles/volume] in Serum or Plasma
625
4315
1.54
19.60
5.2
5.2
mmol/l
1.0
1.0
1.09
563
3961
(3000991) Gas panel - Venous blood
423
2665
1.66
19.52
7.3
7.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1146
8917
1.41
19.30
3.3
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
768
5561
1.48
19.09
1.9
1.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
216
1121
1.98
18.98
2.0
2.2
ug/l
478.8
669.1
0.33
196
1051
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1734
14499
1.36
18.52
2.1
2.0
pmol/l
97.4
96.4
0.32
850
7070
(3014111) Lactate [Moles/volume] in Serum or Plasma
440
2855
1.61
17.99
6.3
6.3
mmol/l
1.4
1.3
1.07
427
2759
(3007853) Bacteria identified in Skin by Aerobe culture
552
3776
1.54
17.94
1.8
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
297
1762
1.74
17.07
8.7
9.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2290
20119
1.34
16.93
3.5
3.1
u/l
47.3
48.5
0.30
2114
18462
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
339
2110
1.67
16.32
3.0
3.2
pmol/l
4.3
4.4
2.12
304
1854
(43055514) Macroprolactin [Presence] in Serum or Plasma
25
37
6.79
16.13
1.6
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
55
162
3.43
15.74
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
2578
23196
1.34
15.38
4.3
3.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
25
39
6.45
15.36
2.0
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
904
6983
1.39
15.26
2.8
2.6
e6/l
6.2
6.3
0.04
812
6084
(3020564) Creatinine [Moles/volume] in Serum or Plasma
3562
33956
1.67
15.22
22.2
17.7
umol/l
74.7
75.3
0.48
3562
33945
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
241
1403
1.77
14.79
6.1
5.5
%
1.5
1.6
1.45
224
1313
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
73
264
2.80
14.78
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
348
2235
1.61
14.76
2.3
2.4
au/ml
17.5
24.9
0.61
11
107
(3023323) Follitropin [Units/volume] in Serum or Plasma
207
1166
1.82
14.19
1.6
1.3
iu/l
31.8
35.1
0.72
184
1013
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
318
2023
1.62
14.01
1.2
1.3
au/ml
45.4
46.4
—
9
94
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
59
196
3.04
13.92
1.2
1.1
nmol/l
9.5
13.0
0.14
14
41
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
79
309
2.59
13.76
1.1
1.1
—
5.0
—
0
6
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1708
14648
1.30
13.74
2.4
2.3
nmol/l
78.0
79.9
2.00
1498
12966
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
696
5252
1.40
13.30
3.0
2.9
e6/l
3.9
3.3
0.62
388
2812
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
745
5703
1.38
13.03
2.8
2.7
e6/l
1.1
1.3
1.06
437
3245
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
297
1903
1.61
12.70
1.4
1.5
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
59
207
2.88
12.68
1.2
1.1
mg/l
55.0
38.5
0.95
53
176
(3008295) Osmolality of Serum or Plasma
86
365
2.39
12.63
1.9
1.4
mosm/kgh2o
283.7
276.2
2.18
70
276
(40761511) CBC panel - Blood by Automated count
3468
33055
1.51
12.47
18.7
14.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1444
12222
1.29
12.46
3.5
3.4
mmol/l
2.4
2.4
0.34
1227
10482
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
47
146
3.25
12.43
1.4
1.4
%
36.5
71.5
—
10
17
(3017446) Testosterone [Moles/volume] in Serum or Plasma
205
1205
1.74
12.19
2.6
2.2
nmol/l
10.6
12.1
1.72
172
1049
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
55
190
2.92
12.17
1.1
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
51
169
3.04
12.13
1.1
1.1
u/l
1.0
1.1
0.86
30
90
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
59
214
2.78
11.95
2.1
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
230
1405
1.68
11.89
6.3
5.5
%
1.0
0.9
1.54
214
1316
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3224
30375
1.38
11.87
17.3
14.1
ml/min/173m2
78.6
77.1
3.83
2859
25083
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
56
199
2.84
11.78
1.1
1.1
mg/l
335.2
260.7
0.94
50
174
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
581
4349
1.40
11.51
7.8
7.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
608
4597
1.38
11.33
2.0
2.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
50
171
2.95
11.28
1.0
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1263
10636
1.28
10.98
2.6
2.5
u/l
60.8
57.6
0.35
1143
9735
(3035637) Corticotropin [Mass/volume] in Plasma
86
391
2.23
10.83
1.8
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1226
10309
1.28
10.74
3.2
3.2
u/l
31.2
33.8
0.91
1144
9761
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
311
2104
1.52
10.48
1.7
1.7
—
—
—
0
0
(3013512) EKG study
1203
10119
1.27
10.44
4.5
4.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1574
13678
1.26
10.35
3.0
2.8
ug/l
126.9
123.0
0.23
1424
12519
(3011985) Renin [Units/volume] in Plasma
92
441
2.11
10.17
1.7
1.4
mu/l
48.0
37.1
0.23
76
388
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
156
895
1.77
10.14
1.7
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1815
16056
1.25
10.11
6.0
5.4
estimate
0.0
0.0
0.80
361
2937
(3039000) Anion gap in Blood
137
759
1.83
10.00
8.2
7.8
mmol/l
10.7
11.1
0.81
121
680
(3018572) Chloride [Moles/volume] in Blood
137
759
1.83
10.00
8.2
7.8
mmol/l
107.3
105.0
6.26
121
680
(3009261) Glucose [Presence] in Urine by Test strip
1833
16251
1.24
9.94
4.5
4.1
estimate
0.0
0.0
1.32
351
2927
(3035350) Ketones [Presence] in Urine by Test strip
1806
15990
1.24
9.90
4.4
4.0
estimate
0.0
0.0
0.00
353
2928
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3176
30041
1.33
9.89
6.4
6.0
mmol/mol
39.7
40.0
1.06
2919
27506
(3037522) Nuclear Ab [Titer] in Serum
568
4343
1.36
9.78
1.4
1.3
titre
542.6
561.0
0.07
117
958
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
514
3870
1.38
9.75
1.8
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
1015
8429
1.28
9.62
6.8
6.8
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
89
431
2.09
9.60
5.7
6.6
mg/l
10.5
12.1
2.44
84
400
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
511
3863
1.37
9.44
1.8
1.8
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
20
41
4.90
9.30
1.4
1.2
%
49.0
51.3
0.07
13
19
(3047181) Lactate [Moles/volume] in Blood
172
1040
1.68
9.29
7.5
6.9
mmol/l
1.3
1.3
0.34
157
912
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
206
1313
1.60
9.05
1.8
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
395
2884
1.41
8.97
3.9
3.4
ng/l
89.1
87.1
0.18
338
2422
(3005719) IgG [Mass/volume] in Serum or Plasma
331
2341
1.45
8.95
3.0
2.7
g/l
9.7
10.4
2.75
297
2126
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
425
3148
1.39
8.87
2.4
2.3
u/l
30.1
37.2
4.14
366
2679
(3021589) Normoblasts [#/volume] in Blood
1613
14219
1.23
8.86
10.6
9.7
e9/l
0.0
0.0
0.06
1311
11554
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1196
10229
1.25
8.64
3.0
3.0
ng/l
1491.6
1411.7
0.25
1025
8778
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
495
3780
1.36
8.55
2.5
2.6
umol/l
7.6
8.3
0.23
412
3276
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
217
1422
1.56
8.48
2.0
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3305
31596
1.33
8.38
5.2
4.8
mmol/l
5.9
5.9
2.27
2992
28534
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3523
34028
1.43
8.32
12.6
11.0
u/l
24.9
24.6
0.43
3415
32687
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
21
50
4.22
8.19
2.5
3.2
umol/l
44.8
41.5
0.24
21
39
(4027681)
42
159
2.66
7.95
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
560
4404
1.32
7.89
1.3
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
979
8260
1.25
7.86
1.6
1.5
nmol/l
20.3
21.2
1.07
832
6941
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
822
6802
1.27
7.80
3.2
3.0
mmol/l
2.5
2.5
0.57
698
5943
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
872
7274
1.26
7.71
1.9
1.7
mg/l
1.5
1.2
0.47
672
5576
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
347
2544
1.40
7.69
1.7
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
141
854
1.68
7.63
1.5
1.4
iu/ml
17.3
19.3
—
5
21
(3003181) Sodium [Moles/volume] in Urine
118
681
1.76
7.60
1.2
1.4
mmol/l
74.3
61.3
2.26
99
551
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1009
8593
1.24
7.36
2.4
2.2
mg/l
3.0
3.1
0.36
850
7301
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1975
17987
1.20
7.21
2.8
2.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
79
412
1.94
7.05
1.6
1.3
pmol/l
250.2
278.1
0.37
65
311
(3036489) Thrombin time
175
1145
1.55
6.94
2.2
1.9
s
21.1
21.6
0.72
155
992
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
92
3.06
6.88
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
65
320
2.05
6.83
2.7
2.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
201
1361
1.50
6.81
1.7
1.9
u/l
36.5
39.4
1.46
171
1211
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
18
45
4.01
6.61
1.0
1.0
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
28
95
2.96
6.53
1.3
1.2
%
18.4
12.9
0.21
12
12
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
890
7564
1.23
6.51
1.7
1.7
pmol/l
10249746.2
27665173.7
0.84
722
6192
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
472
3724
1.30
6.46
4.0
4.1
u/l
241.2
249.5
0.36
440
3494
(3007461) Platelets [#/volume] in Blood
3604
35120
1.42
6.44
28.9
22.4
e9/l
254.2
253.8
0.14
3545
34146
(3000963) Hemoglobin [Mass/volume] in Blood
3605
35140
1.42
6.34
29.1
22.5
g/l
132.0
132.7
2.97
3573
34574
(3024731) MCV [Entitic volume]
3604
35129
1.42
6.34
28.8
22.3
fl
90.9
91.3
6.64
3570
34551
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
10
15
6.68
6.31
1.3
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
3604
35132
1.42
6.30
28.8
22.2
pg
30.2
30.3
4.59
3569
34554
(3026361) Erythrocytes [#/volume] in Blood
3604
35134
1.42
6.28
28.9
22.3
e12/l
4.4
4.4
0.02
3539
34034
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
446
3506
1.31
6.27
3.8
3.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
3604
35136
1.42
6.26
28.9
22.4
e9/l
6.9
6.7
4.77
3540
34033
(3019225) pH of Specimen
463
3662
1.30
6.22
4.9
4.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
31
115
2.71
6.17
1.2
1.1
ng/l
1875.0
368.5
—
5
31
(3002032) Base excess in Venous blood by calculation
387
3000
1.32
6.01
3.9
3.5
mmol/l
1.7
2.1
1.22
325
2470
(3028026) IgM [Mass/volume] in Serum or Plasma
255
1853
1.40
5.99
1.9
1.8
g/l
1.5
1.4
0.17
225
1676
(3009542) Hematocrit [Volume Fraction] of Blood
2969
28306
1.22
5.88
21.0
16.4
%
38.6
38.9
0.84
1997
19104
(3003694) ABO and Rh group [Type] in Blood
932
8030
1.21
5.87
1.3
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
382
2973
1.32
5.77
2.5
2.4
ug/l
6.3
6.3
0.00
316
2554
(3020630) Protein [Mass/volume] in Serum or Plasma
374
2906
1.32
5.72
2.3
2.7
g/l
65.4
66.2
1.68
332
2615
(3012544) pH of Venous blood
397
3117
1.31
5.63
3.8
3.4
—
7.4
—
0
17
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
272
2023
1.37
5.57
3.6
3.6
kpa
5.2
5.2
0.37
242
1873
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3348
32376
1.27
5.53
5.4
5.2
mmol/l
2.8
2.8
0.12
3058
29466
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
11
21
5.25
5.52
1.4
1.3
%
22.0
45.9
0.99
11
14
(3023183) Ammonium ion [Moles/volume] in Plasma
103
630
1.65
5.48
2.2
2.9
umol/l
29.0
33.5
1.84
82
532
(3011397) Hemoglobin [Presence] in Urine by Test strip
902
7798
1.20
5.43
4.1
4.0
—
—
—
0
0
(3009343) pH of Capillary blood
268
2000
1.37
5.38
3.6
3.6
ph
7.4
7.4
2.68
34
254
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3279
31652
1.25
5.38
4.9
4.6
mmol/l
4.7
4.7
0.48
3007
28958
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
131
854
1.55
5.36
2.8
2.4
g/l
3.4
3.6
0.59
125
808
(3021447) Carbon dioxide [Partial pressure] in Venous blood
384
3023
1.30
5.34
3.9
3.4
kpa
5.8
5.8
0.85
377
2940
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
684
5764
1.23
5.33
1.3
1.3
iu/ml
33.0
35.4
0.16
199
1831
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
164
1128
1.47
5.22
3.2
2.9
u/ml
0.3
0.4
0.15
92
657
(40768797) Stomach Pathology biopsy report
579
4806
1.24
5.20
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
338
2628
1.31
5.16
4.5
4.1
%
0.2
0.2
0.08
115
707
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
63
341
1.86
5.13
1.8
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3250
31384
1.23
5.05
4.8
4.6
mmol/l
1.5
1.5
3.10
2955
28521
(3003338) MCHC [Mass/volume]
2755
26205
1.18
5.04
24.9
19.8
g/l
331.1
331.0
0.37
2732
25992
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
24
87
2.77
5.03
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
24
87
2.77
5.03
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
34
147
2.32
5.00
2.2
2.8
u/ml
827.0
1164.7
0.60
34
147
(3052851) Hemolysis interference index of Serum or Plasma
152
1041
1.48
4.96
3.1
3.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
256
1923
1.35
4.95
3.6
3.6
mmol/l
2.2
2.0
0.38
182
1464
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
127
838
1.53
4.95
2.6
2.3
%
182.6
195.4
1.02
121
795
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
15
41
3.67
4.92
1.1
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
154
1061
1.47
4.88
2.0
1.6
titre
248.9
302.5
—
9
48
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
37
168
2.21
4.87
2.3
2.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
12
28
4.30
4.82
1.0
1.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
381
3038
1.28
4.81
2.5
3.0
ng/l
170.7
194.7
0.79
347
2770
(3017181) Myelocytes/100 leukocytes in Blood
350
2763
1.29
4.78
4.5
4.0
%
1.0
0.9
0.21
122
772
(3049242) von Willebrand panel - Platelet poor plasma
8
7
11.45
4.78
2.5
3.0
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
10
20
5.01
4.77
1.4
1.4
%
21.8
13.8
—
10
14
(3024980) IgG subclass 4 [Mass/volume] in Serum
80
476
1.70
4.77
1.6
1.6
g/l
0.7
0.8
0.25
66
356
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
30
126
2.39
4.72
1.2
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
44
217
2.04
4.71
6.8
6.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
19
63
3.03
4.66
1.2
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
316
2470
1.30
4.66
4.5
4.1
%
0.0
0.6
1.49
98
606
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
15
43
3.50
4.61
1.1
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2729
26017
1.17
4.54
23.5
18.4
%
13.8
13.8
0.32
2676
25427
(3028433) Virus identified in Specimen by Culture
27
110
2.46
4.54
1.2
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
34
3.83
4.53
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
78
468
1.68
4.53
1.5
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
60
334
1.81
4.52
1.4
1.4
nmol/l
0.3
0.3
0.05
43
240
(3004588) Protein electrophoresis panel - Serum or Plasma
310
2431
1.30
4.47
2.2
2.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
953
8406
1.18
4.47
2.8
2.6
umol/l
3017.2
5718.2
1.68
806
7167
(3015171) Extractable nuclear Ab [Units/volume] in Serum
180
1301
1.40
4.44
1.3
1.2
u/ml
0.2
1.4
2.47
15
123
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1007
8927
1.17
4.43
1.6
1.6
mmol/l
1.4
1.3
1.03
867
7440
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
74
443
1.68
4.34
1.4
1.3
nmol/l
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
315
2491
1.29
4.27
3.8
2.8
kpa
4.7
4.5
0.74
305
2415
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3135
30281
1.19
4.24
4.3
4.1
mmol/l
1.3
1.3
0.29
2824
27249
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1339
12172
1.15
4.20
4.9
4.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
689
5948
1.19
4.12
1.5
1.4
g/l
2.3
2.4
1.72
401
3433
(3012501) Base excess in Blood by calculation
109
727
1.51
4.11
3.2
4.2
mmol/l
2.2
2.8
1.70
80
519
(3008757) Leukocyte morphology finding [Identifier] in Blood
63
368
1.72
4.07
4.5
4.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
464
3861
1.23
4.06
1.5
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
969
8620
1.17
4.03
5.0
4.5
estimate
0.0
0.0
1.49
350
2883
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
134
936
1.45
4.02
1.7
1.6
g/l
0.2
0.2
0.94
122
890
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
55
310
1.79
4.01
5.8
4.7
u/ml
9.9
48.2
4.04
16
85
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
138
971
1.44
3.99
1.7
1.6
g/l
1.2
1.2
0.50
126
924
(46235355) HIV 1 and 2 tests - Meaningful Use set
447
3713
1.23
3.98
1.7
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
103
685
1.52
3.95
2.6
2.9
kpa
8.5
8.0
0.56
95
632
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
56
321
1.76
3.87
1.9
1.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
14
44
3.19
3.77
1.1
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
329
2659
1.26
3.76
3.1
2.7
ml/min/173m2
61.8
63.7
0.35
120
1105
(40767503) Oxygen content in Capillary blood by calculation
102
688
1.50
3.68
2.5
2.5
%
15.4
16.0
0.78
50
346
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
9
16
5.64
3.65
1.2
1.2
%
2.7
0.9
—
9
10
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
18
67
2.69
3.65
1.1
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
20
79
2.54
3.62
1.1
1.1
umol/24h
0.7
0.7
0.02
11
41
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
79
2.54
3.62
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
287
2293
1.27
3.62
3.4
3.0
e9/l
4.1
4.0
0.18
204
1720
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
527
4496
1.20
3.59
2.8
2.5
%
21.3
22.1
0.56
461
3764
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
120
841
1.44
3.58
1.8
2.1
mg/l
12.1
11.6
0.11
108
775
(3010421) pH of Blood
123
867
1.43
3.56
3.2
4.0
ph
7.4
7.4
0.02
108
717
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
19
74
2.58
3.54
3.5
2.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
21
86
2.45
3.54
1.0
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
562
4829
1.19
3.53
2.7
2.4
g/l
2.3
2.3
0.49
513
4431
(3022217) INR in Platelet poor plasma by Coagulation assay
532
4554
1.20
3.49
25.1
25.9
inr
1.4
1.4
0.26
79
631
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
127
904
1.42
3.49
1.2
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
30
145
2.08
3.47
1.3
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
87
2.42
3.46
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
51
295
1.74
3.46
1.1
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
56
333
1.69
3.44
3.4
3.5
%
63.0
57.5
1.07
42
217
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
118
831
1.43
3.44
1.8
1.8
iu/l
4.1
4.7
0.25
40
287
(4211845)
34
173
1.97
3.43
4.1
3.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
114
799
1.44
3.41
2.6
3.1
mmol/l
25.1
25.1
0.02
99
697
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
174
1310
1.34
3.41
2.3
1.9
ug/l
2.6
1.9
0.33
137
1147
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
105
725
1.46
3.40
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
105
725
1.46
3.40
1.6
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
351
2892
1.24
3.40
1.6
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
19
76
2.51
3.37
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
86
572
1.52
3.35
2.3
2.8
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
11
32
3.44
3.33
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
86
573
1.51
3.32
1.9
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
355
2939
1.23
3.29
4.3
3.7
mmol/l
1.2
1.2
0.43
315
2536
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
42
233
1.81
3.29
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
46
263
1.76
3.26
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
309
2523
1.24
3.26
4.3
3.9
%
1.0
0.6
0.40
92
550
(40761535) Cells panel - Urine sediment
347
2870
1.23
3.25
3.7
3.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
189
1455
1.31
3.20
3.9
3.7
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
31
157
1.98
3.19
4.0
3.7
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
49
2.86
3.19
1.1
1.0
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
30
151
1.99
3.14
2.0
1.7
nmol/l
9.6
4.5
0.49
25
125
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
506
4355
1.19
3.13
4.9
4.7
%
33.0
33.4
0.33
351
2846
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
627
5496
1.17
3.11
1.3
1.3
u/ml
6.6
13.0
2.19
228
2059
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
43
245
1.76
3.10
2.4
2.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
149
1114
1.35
3.09
3.5
3.3
mg/l
31.3
108.1
0.91
123
932
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
39
3.08
3.09
1.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
37
202
1.84
3.07
4.1
3.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
16
5.01
3.05
1.0
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
41
233
1.77
2.99
1.2
1.1
titre
110.0
177.3
—
5
41
(4062490)
50
301
1.67
2.98
1.6
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
148
1113
1.34
2.97
3.6
3.3
mg/l
28.2
55.1
1.52
122
930
(40760888) Immunoglobulin light chains.free panel - Serum
112
806
1.40
2.95
3.7
3.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
205
1615
1.28
2.94
3.9
3.1
mmol/l
25.2
25.5
0.68
200
1569
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
95
664
1.44
2.94
1.6
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
144
1081
1.35
2.92
3.6
3.3
ratio
1.2
1.5
—
8
91
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
46
2.83
2.91
1.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
191
1494
1.29
2.90
3.7
3.7
mmol/l
24.1
24.3
0.41
181
1344
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
33
177
1.87
2.90
3.1
2.3
e6/l
858.4
671.5
0.74
18
73
(3041096) Erythrocytes [Presence] in Urine by Automated
924
8368
1.14
2.89
4.4
3.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
598
5255
1.16
2.87
2.7
2.4
umol/l
12.4
12.6
0.25
553
4816
(1002224) Polysomnography panel
141
1063
1.34
2.80
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
99
708
1.41
2.72
2.8
3.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
104
751
1.40
2.71
2.0
2.2
g/l
124.8
127.1
0.46
70
530
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
10
6.01
2.70
1.2
1.0
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
11
37
2.98
2.69
1.1
1.1
ng/l
49.0
89.6
—
5
27
(3021879) Hepatitis B virus core Ab [Presence] in Serum
229
1852
1.25
2.68
1.4
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
107
780
1.38
2.64
1.8
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
104
755
1.39
2.64
1.3
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
18
80
2.26
2.60
1.2
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
245
2006
1.24
2.57
3.7
3.0
g/l
127.1
127.5
0.11
240
1956
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
19
87
2.19
2.57
1.1
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
19
87
2.19
2.57
1.2
1.1
pmol/l
189.5
322.1
1.48
11
64
(3024139) IgG subclass 3 [Mass/volume] in Serum
48
300
1.61
2.53
1.6
1.4
g/l
0.3
0.4
1.02
38
210
(3028192) IgG subclass 2 [Mass/volume] in Serum
48
300
1.61
2.53
1.6
1.4
g/l
2.6
2.8
0.36
38
213
(3027135) IgG subclass 1 [Mass/volume] in Serum
48
300
1.61
2.53
1.6
1.4
g/l
5.9
7.1
1.90
38
211
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
177
1399
1.28
2.52
1.9
2.4
g/l
3.5
3.7
2.37
123
987
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
177
1400
1.28
2.51
1.9
2.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
79
552
1.44
2.50
4.3
3.5
%
1.8
1.4
0.28
63
426
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
384
3296
1.18
2.48
1.6
1.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
26
3.47
2.48
1.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
21
102
2.06
2.47
1.5
1.2
g/l
36.6
38.3
0.30
14
51
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
93
671
1.40
2.47
1.2
1.3
u/ml
23.3
45.1
—
9
78
(3025315) Body weight
8
21
3.81
2.46
6.1
5.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
65
441
1.48
2.40
1.2
1.2
u/ml
8.5
3.4
0.58
16
136
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
176
1401
1.27
2.39
1.9
2.4
g/l
7.4
7.5
0.34
127
1032
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
122
926
1.33
2.36
1.3
1.3
u/ml
33.3
43.2
—
9
58
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
64
436
1.48
2.32
1.3
1.2
u/ml
3.4
4.8
0.69
25
173
(3027945) Reticulocytes/100 erythrocytes in Blood
435
3798
1.16
2.29
2.5
2.4
%
1.8
1.8
0.13
389
3350
(3019150) Specific gravity of Urine by Refractometry
772
7009
1.13
2.29
4.9
4.6
kg/l
1.0
1.0
0.00
140
1068
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
14
59
2.38
2.29
1.4
1.3
ng/l
109.6
82.4
0.59
14
59
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
165
1311
1.27
2.28
1.9
2.4
g/l
3.1
3.1
0.29
123
1008
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
65
446
1.47
2.28
2.2
2.4
u/ml
256.0
1072.2
—
5
30
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
11
41
2.69
2.27
1.1
1.1
umol/24h
1.5
1.7
0.38
11
41
(4010399)
289
2445
1.20
2.22
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
102
762
1.35
2.22
1.9
1.5
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
10
36
2.78
2.20
1.6
1.3
mmol/l
5.9
6.1
—
5
21
(3037756) Immunofixation for Serum or Plasma
99
739
1.35
2.17
1.5
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
57
386
1.48
2.15
3.1
3.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
218
1801
1.22
2.15
4.5
3.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
61
419
1.46
2.15
2.7
2.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
44
282
1.57
2.13
2.5
1.8
—
1.1
—
0
12
(1761482) Bacteria [#/volume] in Urine by Culture
117
898
1.31
2.13
5.3
4.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
163
1306
1.26
2.13
2.0
2.4
g/l
9.4
10.2
1.96
134
1084
(3022621) pH of Urine by Test strip
270
2285
1.20
2.09
3.7
3.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
192
1571
1.23
2.08
2.0
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
49
324
1.52
2.08
2.8
3.9
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
158
1265
1.26
2.08
4.4
3.8
mmol/l
25.1
25.1
0.03
143
1153
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
71
506
1.41
2.07
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
53
359
1.48
2.02
1.6
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
758
6926
1.12
2.01
1.3
1.2
u/ml
0.9
1.6
3.46
179
1777
(3020191) Ethanol [Moles/volume] in Serum or Plasma
33
201
1.65
1.98
1.6
1.4
promille
0.8
1.1
0.42
23
156
(40760892) CBC W Ordered Manual Differential panel - Blood
742
6779
1.12
1.98
4.7
4.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
34
209
1.63
1.97
3.0
3.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
134
1061
1.27
1.95
1.3
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
70
504
1.40
1.94
1.9
1.8
u/l
5526.6
2565.4
0.42
25
195
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
52
354
1.48
1.94
1.7
1.4
u/l
32.4
36.2
0.34
47
288
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
119
929
1.29
1.94
1.5
1.6
iu/ml
0.1
6.1
0.50
31
202
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
5
11
4.55
1.94
1.0
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
183
1504
1.23
1.93
3.1
2.5
%
0.6
0.7
0.20
176
1443
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
103
791
1.31
1.90
1.4
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
145
1166
1.25
1.87
2.9
3.0
g/l
0.3
0.3
0.41
63
417
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
63
449
1.41
1.87
1.7
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
15
72
2.09
1.86
1.3
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
42
277
1.52
1.84
1.4
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
368
3232
1.15
1.83
2.1
2.1
g/l
0.2
0.2
0.71
331
3015
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
43
286
1.51
1.81
2.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
43
286
1.51
1.81
2.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
43
286
1.51
1.81
2.1
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
53
2.27
1.80
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
12
53
2.27
1.80
1.2
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
42
280
1.51
1.76
1.3
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
118
934
1.27
1.76
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
36
232
1.56
1.75
2.1
2.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
146
1185
1.24
1.75
2.4
2.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
98
758
1.30
1.74
1.3
1.2
—
—
—
0
0
(4024509)
56
397
1.42
1.73
2.0
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
287
2489
1.17
1.71
1.2
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
11
48
2.30
1.70
1.3
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
137
1110
1.24
1.68
1.9
2.3
g/l
37.3
37.5
0.15
115
934
(3011412) CD3 cells [#/volume] in Blood
40
267
1.50
1.68
2.7
2.1
e9/l
1.0
1.1
0.24
18
173
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
76
571
1.34
1.67
5.0
5.0
iu/ml
149.8
631.5
1.29
12
81
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
513
4637
1.12
1.66
1.4
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
126
1014
1.25
1.65
2.0
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
16
83
1.93
1.64
1.1
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
16
83
1.93
1.64
1.1
1.1
%
89.8
86.7
—
9
42
(3051593) INR in Capillary blood by Coagulation assay
28
173
1.62
1.63
11.3
11.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
49
2.25
1.63
1.7
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
959
10245
0.91
1.63
3.1
3.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
23
135
1.71
1.62
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
62
454
1.37
1.61
1.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
67
497
1.35
1.61
1.4
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
129
1045
1.24
1.60
1.5
1.4
ug/g
297.0
280.2
0.39
73
598
(3024522) Salmonella sp identified in Specimen by Organism specific culture
62
457
1.36
1.56
1.6
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
147
1213
1.22
1.55
1.7
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
19
107
1.78
1.54
1.1
1.1
miu/ml
1606.7
1701.7
0.11
19
107
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
13
64
2.03
1.54
2.3
2.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
650
5981
1.10
1.52
5.9
5.2
ug/l
2.7
3.2
0.92
577
5283
(21494434) Karyotype in Bone marrow
44
307
1.44
1.51
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
93
1.83
1.51
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
61
451
1.36
1.51
1.6
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
118
954
1.24
1.51
1.6
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
62
460
1.35
1.50
1.3
1.3
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
16
86
1.86
1.50
1.1
1.3
nmol/l
109.6
120.6
—
8
61
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
62
461
1.35
1.49
2.5
2.2
mg/l
34.6
25.4
0.51
18
118
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
145
1201
1.22
1.48
2.1
2.5
g/l
0.5
1.0
1.58
125
1025
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
13
65
2.00
1.48
1.3
1.2
—
—
—
0
0
(4268621)
42
292
1.44
1.48
2.5
2.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
266
2323
1.16
1.48
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
59
436
1.36
1.47
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
54
394
1.38
1.46
1.8
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
61
454
1.35
1.46
1.6
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
88
691
1.28
1.45
1.2
1.2
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
11
52
2.12
1.44
1.2
1.6
ug/l
81.0
113.0
—
6
46
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
62
464
1.34
1.43
1.6
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
128
1051
1.23
1.43
1.9
2.4
g/l
0.0
0.0
1.36
115
958
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
34
228
1.50
1.43
1.0
1.0
ng/l
782.9
707.5
0.31
20
143
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
119
970
1.23
1.43
2.0
2.4
g/l
0.0
0.0
0.00
107
895
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
63
474
1.33
1.41
1.2
1.2
u/ml
300.8
292.0
0.09
38
277
(3022145) Colonoscopy Study observation
416
3755
1.12
1.41
1.3
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
32
213
1.51
1.40
2.1
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
26
165
1.58
1.40
2.4
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
26
165
1.58
1.40
2.4
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
26
165
1.58
1.40
2.4
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
26
165
1.58
1.40
2.4
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
62
467
1.33
1.38
1.8
1.8
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
34
230
1.48
1.38
1.0
1.0
ng/l
33.2
45.4
1.21
22
143
(3023520) Reticulocytes [#/volume] in Blood
321
2856
1.14
1.38
2.8
2.4
e9/l
70.9
70.6
0.07
254
2154
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
24
150
1.60
1.37
1.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
9
41
2.20
1.37
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
60
451
1.34
1.36
1.6
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
120
985
1.23
1.36
2.0
2.4
g/l
0.0
0.0
0.00
107
897
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
38
264
1.44
1.36
1.6
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
75
584
1.29
1.33
1.7
1.5
—
—
—
0
0
(4198724)
11
54
2.04
1.32
1.5
1.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
83
1.81
1.31
1.1
1.3
%
97.1
87.0
—
9
43
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
24
2.50
1.30
1.0
4.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
381
3440
1.12
1.30
3.4
3.2
ug/l
0.9
0.8
0.83
277
2384
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
42
301
1.40
1.29
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
205
1778
1.16
1.28
1.4
1.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
20
122
1.64
1.27
1.5
2.4
umol/l
200.8
156.0
—
9
68
(37021550) Renin [Units/volume] in Plasma --upright
15
84
1.79
1.27
1.2
1.3
mu/l
107.5
64.6
—
9
64
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
34
235
1.45
1.27
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
34
235
1.45
1.27
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1081
10255
1.08
1.25
3.1
3.1
mmol/l
6.8
6.8
0.19
902
8508
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
34
236
1.44
1.24
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
34
236
1.44
1.24
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
34
236
1.44
1.24
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
34
236
1.44
1.24
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
203
1.48
1.24
1.6
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
73
573
1.28
1.24
1.7
2.0
nmol/l
0.8
0.8
0.06
66
473
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
8
36
2.22
1.24
2.5
2.8
u/field
0.4
0.7
—
8
36
(4306422)
57
433
1.32
1.23
1.2
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
27
179
1.51
1.23
1.1
1.1
ratio
1.0
1.0
—
8
60
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
61
469
1.31
1.21
1.4
1.3
u/ml
103.8
120.1
—
10
99
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
68
531
1.29
1.21
1.5
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
16
93
1.72
1.21
1.3
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
21
132
1.59
1.20
2.7
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
21
132
1.59
1.20
2.7
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
413
3765
1.11
1.19
2.0
2.1
ug/g
111.7
133.3
0.89
309
2907
(3048879) Bone marrow aspiration report
17
101
1.69
1.19
1.9
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
71
1.83
1.19
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
38
272
1.40
1.19
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
65
506
1.29
1.19
1.8
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
105
865
1.22
1.19
1.3
1.3
u/ml
14.3
7.7
0.33
18
161
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
10
187
0.53
1.18
1.8
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
34
239
1.43
1.18
1.7
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
46
341
1.35
1.18
2.9
2.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
65
507
1.29
1.17
1.8
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
133
1.58
1.17
2.7
1.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
57
1.93
1.17
1.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
73
580
1.26
1.15
1.9
1.6
—
—
—
0
0
(3036603) Volume of Urine
32
224
1.43
1.14
1.4
1.4
ml
1883.4
1789.9
—
8
50
(3012516) Albumin [Mass/volume] in Urine
1043
9915
1.07
1.13
3.1
3.2
mg/l
544.1
361.7
0.46
630
5945
(3028300) Cannabinoids [Presence] in Urine
65
510
1.28
1.13
1.8
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1097
10449
1.07
1.12
3.8
3.9
mg/mmol
8.1
8.1
0.00
659
6270
(40768443) Skin Pathology biopsy report
176
1527
1.16
1.12
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
225
1987
1.14
1.12
2.6
2.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
94
771
1.22
1.12
2.7
3.0
mg/l
1.6
1.6
0.20
88
707
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
53
405
1.31
1.12
2.0
1.5
%
63.4
59.6
0.34
38
262
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
40
2.00
1.12
1.9
2.0
umol/l
19.8
20.1
—
8
40
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
103
854
1.21
1.11
1.3
1.3
u/ml
2.1
6.4
—
10
95
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
93
764
1.22
1.10
1.1
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
32
226
1.42
1.09
1.0
1.0
ng/l
329.5
324.7
0.03
22
143
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
21
2.38
1.09
1.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
32
2.19
1.08
1.1
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
10
52
1.93
1.06
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
63
498
1.27
1.05
1.6
1.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
39
288
1.36
1.04
1.9
2.2
u/field
1.4
2.0
0.60
15
111
(21494755) Public health laboratory ask at order entry panel
173
1976
0.87
1.04
1.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
276
0.65
1.03
1.3
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
63
500
1.26
1.02
1.2
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
35
255
1.38
1.02
1.2
1.1
u/ml
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
118
1001
1.18
1.02
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
85
699
1.22
1.01
1.6
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
100
836
1.20
1.01
2.2
2.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
32
231
1.39
0.99
1.2
2.5
mmol/l
7.2
6.9
0.33
21
147
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
95
793
1.20
0.98
1.4
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
102
858
1.19
0.97
1.2
1.2
titre
40.0
95.9
—
6
63
(42529406) Shigella sp [Presence] in Stool by Culture
118
1006
1.18
0.97
1.3
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
25
173
1.45
0.97
1.9
1.9
u/field
0.8
3.1
1.41
16
124
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
36
1.95
0.97
31.1
13.2
mmol/l
4.6
5.2
—
7
36
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
36
1.95
0.97
1.1
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
39
293
1.33
0.96
1.1
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
31
421
0.73
0.94
1.3
1.5
e6/l
1650.4
2292.3
0.52
24
311
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
515
4806
1.08
0.93
5.0
4.5
%
22.4
21.5
0.74
274
2428
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
16
101
1.59
0.93
2.1
1.5
ug/l
0.5
0.4
0.18
11
58
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
116
994
1.17
0.91
1.3
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
32
235
1.36
0.91
2.3
2.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
218
0.64
0.88
1.4
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
418
3878
1.09
0.88
3.6
3.9
ug/l
15.0
22.1
0.34
333
3131
(40761536) Microorganisms panel - Urine sediment
303
2770
1.10
0.88
5.2
4.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
25
177
1.42
0.88
1.7
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
25
178
1.41
0.86
1.7
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
228
0.66
0.85
1.4
1.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
31
1.94
0.84
1.5
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
31
1.94
0.84
7.0
1.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
14
88
1.59
0.84
1.4
1.9
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
18
262
0.69
0.83
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
18
262
0.69
0.83
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
85
716
1.19
0.83
1.8
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
18
261
0.69
0.82
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
18
261
0.69
0.82
1.3
1.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
32
1.88
0.81
1.8
2.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
38
293
1.30
0.81
3.2
2.8
mg/l
21.8
28.2
0.25
29
213
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
56
454
1.24
0.80
1.5
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
37
285
1.30
0.80
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
102
1182
0.86
0.79
1.4
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
144
1271
1.14
0.79
3.0
3.2
u/ml
2776.7
3475.2
0.09
117
1069
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
0.1
—
0
12
(3032868) Hemoglobin electrophoresis panel in Blood
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
48
384
1.25
0.78
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
167
1490
1.13
0.78
1.4
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
30
225
1.34
0.78
1.9
2.0
%
41.8
43.9
—
6
23
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
30
395
0.76
0.78
1.1
1.1
g/l
1.6
1.5
0.57
24
352
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
18
123
1.47
0.77
1.2
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
32
243
1.32
0.77
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
53
430
1.24
0.77
2.0
2.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
17
115
1.48
0.76
1.0
1.0
u/ml
0.2
0.9
—
6
41
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
2.8
—
0
6
(3001686) Cold agglutinin [Titer] in Serum or Plasma
11
67
1.64
0.75
1.2
1.3
titre
—
119.7
—
0
13
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
12
75
1.60
0.74
1.2
1.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
24
2.08
0.74
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
22
158
1.39
0.74
1.2
1.3
nmol/l
133.6
134.3
0.04
22
158
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
218
0.69
0.71
1.3
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
78
664
1.18
0.71
1.3
1.3
miu/ml
187.8
215.4
0.26
33
297
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
62
517
1.20
0.71
1.8
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
31
238
1.30
0.70
1.9
2.2
ml
639.6
626.4
0.07
19
158
(3005033) Fetal Nuchal fold Thickness US
15
217
0.69
0.70
1.3
1.4
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
22
160
1.38
0.70
1.2
1.2
u/l
173.2
267.6
0.62
17
147
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
101
881
1.15
0.68
1.8
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
27
1.85
0.68
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
12
77
1.56
0.68
1.1
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
12
77
1.56
0.68
1.2
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
25
187
1.34
0.68
1.9
1.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
239
2195
1.09
0.68
2.9
3.9
u/ml
43.0
65.8
0.91
229
2111
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
32
249
1.29
0.67
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
76
650
1.17
0.67
2.7
2.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
49
402
1.22
0.66
2.7
2.0
u/ml
4256.5
988.4
0.36
49
393
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
28
1.79
0.66
1.0
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
54
448
1.21
0.66
1.7
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
18
128
1.41
0.65
2.4
2.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
206
1883
1.10
0.65
1.3
1.2
u/ml
174.2
184.8
0.08
187
1722
(44806420)
15
103
1.46
0.65
2.7
2.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
21
154
1.37
0.65
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
316
2946
1.08
0.64
1.6
1.7
%
1.4
1.5
0.05
268
2553
(3024928) Oxygen saturation in Venous blood
76
653
1.17
0.64
3.1
2.7
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
29
1.73
0.64
1.2
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
5
29
1.73
0.64
1.0
1.2
g/l
17.1
17.8
—
5
23
(3038177) Helicobacter pylori Ab [Presence] in Serum
56
469
1.20
0.63
1.4
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
194
2120
0.91
0.62
1.8
1.7
—
—
—
0
0
(3000492) Spirometry study
305
2846
1.08
0.61
1.5
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
14
96
1.46
0.61
2.3
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
92
806
1.14
0.61
3.5
3.2
nmol/l
0.8
0.8
0.50
66
624
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
46
380
1.21
0.60
1.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
26
334
0.78
0.60
1.4
1.5
—
—
—
0
0
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.1
—
0.1
—
0
10
(3010726) Horse dander IgE Ab [Units/volume] in Serum
39
318
1.23
0.58
1.1
1.1
u/ml
1.0
1.6
—
7
75
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
36
291
1.24
0.58
1.7
1.5
%
21.1
32.9
1.41
25
182
(3028308) Erythrocytes [#/volume] in Pleural fluid
30
376
0.80
0.57
1.3
1.4
e6/l
5947.5
74329.7
2.33
19
218
(3039162) Centromere protein B Ab [Units/volume] in Serum
49
410
1.20
0.57
1.1
1.3
u/ml
40.9
48.0
—
5
28
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
172
1572
1.10
0.57
1.1
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
155
1410
1.10
0.56
1.4
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
22
167
1.32
0.56
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
125
1124
1.12
0.56
2.9
2.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
32
256
1.25
0.56
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
114
1020
1.12
0.56
1.4
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
43
356
1.21
0.56
1.2
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
87
0.57
0.56
1.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
234
2172
1.08
0.55
1.2
1.2
iu/ml
164.7
148.1
0.25
78
815
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
39
471
0.83
0.54
1.4
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
38
1.58
0.54
2.7
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
60
1.50
0.54
2.6
1.7
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
22
169
1.30
0.53
1.1
1.3
—
1.6
—
0
13
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
15
108
1.39
0.53
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
36
295
1.22
0.52
1.1
1.2
nmol/l
338.9
368.7
0.39
28
247
(3005570) Glucose [Moles/volume] in Urine
43
359
1.20
0.52
2.0
2.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
24
187
1.29
0.52
1.1
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
20
260
0.77
0.52
1.4
1.7
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
40
1.50
0.51
2.7
2.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
28
224
1.25
0.50
1.6
1.3
—
—
—
0
0
(44806118)
43
361
1.19
0.50
1.6
1.4
—
—
—
0
0
(44790048)
43
361
1.19
0.50
1.6
1.4
—
—
—
0
0
(44790047)
43
361
1.19
0.50
1.6
1.4
—
—
—
0
0
(44790049)
43
361
1.19
0.50
1.6
1.4
—
—
—
0
0
(4034850)
118
1067
1.11
0.50
8.3
10.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
31
252
1.23
0.49
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
24
189
1.27
0.49
1.3
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
27
216
1.25
0.49
1.1
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
45
1.56
0.49
1.9
2.3
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
11
76
1.45
0.48
2.6
3.8
ng/l
71.4
184.7
—
5
32
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
47
1.49
0.47
1.1
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
130
1422
0.91
0.47
1.4
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
49
420
1.17
0.46
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
20
155
1.29
0.46
5.2
3.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
92
825
1.12
0.46
1.4
1.5
—
—
—
0
0
(44813793)
27
218
1.24
0.46
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
27
218
1.24
0.46
1.5
1.5
g/l
0.9
1.0
0.22
27
218
(3002523) Influenza virus A Ag [Presence] in Specimen
41
347
1.18
0.45
1.0
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
22
174
1.27
0.44
1.7
2.1
min
476.3
492.6
0.30
15
128
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
28
229
1.22
0.43
1.6
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
165
1530
1.08
0.43
1.7
1.7
g/l
1.6
1.6
0.03
143
1301
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
54
470
1.15
0.43
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
31
1.61
0.43
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
76
850
0.89
0.43
1.6
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
546
5669
0.96
0.42
1.4
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
50
434
1.15
0.42
1.7
1.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
21
167
1.26
0.41
2.2
1.8
mmol/l
8.5
9.4
0.97
15
133
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
41
351
1.17
0.41
1.1
1.2
mmol/l
7.7
7.5
0.15
32
252
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
88
1.36
0.40
1.1
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
35
1.43
0.39
1.0
1.7
—
—
—
0
0
(3024316) Viscosity of Plasma
0
19
0.00
0.39
0.0
1.6
—
1.7
—
0
14
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
19
0.00
0.39
0.0
2.7
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
14
106
1.32
0.39
1.8
1.8
u/l
13.9
67.3
1.52
14
100
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
23
187
1.23
0.39
1.3
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
48
419
1.15
0.38
1.1
1.1
u/ml
0.7
1.3
0.51
15
163
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
56
495
1.13
0.38
1.6
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
12
89
1.35
0.37
1.2
1.1
—
—
—
0
0
(4094501)
97
886
1.10
0.37
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
20
161
1.24
0.37
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
72
1.39
0.36
1.6
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
180
0.78
0.36
1.5
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
40
347
1.15
0.35
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
184
1732
1.07
0.35
1.8
1.8
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
9
126
0.71
0.35
8.7
12.8
nmol/l
1020.6
837.7
—
9
120
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
73
1.37
0.34
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
20
243
0.82
0.33
1.7
1.8
%
11.8
11.0
0.33
20
243
(3009871) Measles virus Ab [Titer] in Serum
12
91
1.32
0.33
1.7
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
63
567
1.11
0.33
1.7
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
109
1.29
0.33
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
46
1.30
0.33
2.0
2.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
16
128
1.25
0.31
1.1
1.5
umol/l
34.3
30.7
0.91
16
122
(3003888) Timothy IgE Ab [Units/volume] in Serum
41
361
1.14
0.31
1.0
1.1
u/ml
1.8
3.4
0.82
16
171
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
162
1527
1.06
0.31
1.7
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
40
352
1.14
0.31
1.1
1.1
u/ml
0.9
1.1
0.12
13
143
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
7
53
1.32
0.30
2.7
2.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
90
830
1.09
0.30
1.0
1.1
u/ml
2.4
6.2
—
8
81
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
120
1.25
0.30
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
55
1.27
0.30
1.1
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
21
176
1.19
0.28
1.8
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
130
1.23
0.28
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
48
431
1.12
0.28
1.4
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
42
374
1.12
0.28
1.3
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
15
122
1.23
0.27
1.7
1.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
24
206
1.17
0.26
1.9
2.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
77
1.30
0.26
1.1
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
74
0.68
0.26
4.0
3.0
mg/l
3.3
7.7
—
5
62
(4146454)
35
394
0.89
0.26
3.2
2.7
—
—
—
0
0
(3019977) pH of Arterial blood
20
169
1.18
0.25
1.5
2.9
ph
7.4
7.4
—
8
58
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
149
0.80
0.25
1.4
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
32
282
1.14
0.25
3.9
2.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
95
1016
0.93
0.25
1.8
1.7
mg/l
3.5
3.5
0.03
73
752
(3047007) Chlamydophila sp Ab [Presence] in Serum
45
406
1.11
0.25
1.2
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
35
312
1.12
0.24
1.1
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
29
256
1.13
0.23
1.1
1.1
u/ml
6.6
3.1
—
10
97
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
42
380
1.11
0.23
1.4
1.2
u/l
59.3
56.8
0.12
26
263
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
65
602
1.08
0.22
2.1
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
51
467
1.09
0.22
1.0
1.1
—
—
—
0
0
(44806071)
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
69
741
0.93
0.21
2.1
2.3
ug/min
70.4
95.0
0.31
30
433
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
52
478
1.09
0.21
1.0
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
11
0.00
0.21
0.0
8.6
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(3013762) Body weight Measured
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
105
0.76
0.21
2.1
1.9
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
19
164
1.16
0.20
1.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
2.4
—
0
14
(21494890) Protein electrophoresis panel - 24 hour Urine
39
355
1.10
0.20
3.0
1.9
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
20
174
1.15
0.19
1.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
19
165
1.15
0.19
1.6
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
19
165
1.15
0.19
1.0
1.0
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
213
1.13
0.18
2.0
2.0
%
17.0
14.2
—
9
84
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
20
175
1.14
0.18
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
59
1.19
0.18
2.4
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
13
153
0.85
0.18
2.4
1.8
ug/l
1.1
5.4
—
8
113
(40768806) Pleura Pathology biopsy report
32
352
0.91
0.18
1.7
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
61
1.15
0.17
1.9
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
61
1.15
0.17
1.1
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
38
413
0.92
0.17
1.3
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
68
1.18
0.16
1.3
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
96
915
1.05
0.16
1.9
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
8
72
1.11
0.16
1.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
78
0.77
0.15
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
49
458
1.07
0.15
2.2
2.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
28
307
0.91
0.15
1.4
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
69
727
0.95
0.14
3.1
3.8
mg/l
30.1
25.9
0.28
34
442
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
210
2044
1.03
0.14
1.3
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
10
84
1.19
0.14
1.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
8
99
0.81
0.13
1.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
99
0.81
0.13
1.5
1.6
ug/l
11.1
8.7
—
8
99
(3010144) Erythrocytes [#/volume] in Synovial fluid
31
335
0.92
0.13
1.7
1.3
e6/l
20049.4
101096.4
1.37
21
215
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
26
238
1.09
0.13
1.5
1.5
u/l
2.4
6.3
2.37
11
112
(3025018) Bordetella pertussis Ab [Titer] in Serum
15
169
0.89
0.12
1.1
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
19
210
0.90
0.12
1.1
1.3
mmol/l
9.3
11.5
—
7
57
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
41
385
1.07
0.12
1.0
1.0
u/ml
3.5
3.3
0.05
18
152
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
34
363
0.94
0.11
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
42
444
0.95
0.10
1.2
1.1
iu/ml
13.9
1400.7
—
8
93
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
98
1013
0.97
0.10
1.5
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
30
280
1.07
0.10
1.0
1.0
u/ml
9.8
2.5
—
8
102
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
63
604
1.04
0.10
1.4
1.3
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
5
44
1.14
0.10
2.6
1.7
mmol/l
1.7
3.1
—
5
35
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
25
233
1.07
0.09
1.2
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
45
429
1.05
0.09
1.2
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
107
1.12
0.08
2.0
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
58
1.03
0.08
2.3
2.7
—
—
—
0
0
(4133840)
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
65
1.08
0.08
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
32
338
0.95
0.08
1.6
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
66
1.06
0.08
1.3
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
67
1.04
0.08
1.0
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
70
0.86
0.07
1.7
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
8
74
1.08
0.07
2.6
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
37
353
1.05
0.07
1.5
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
7
85
0.82
0.07
2.3
1.8
mmol/l
-0.2
1.1
—
7
78
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
90
0.89
0.06
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
103
0.87
0.06
3.2
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
56
542
1.03
0.06
1.7
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
68
661
1.03
0.06
3.1
3.5
%
56.7
57.9
0.31
68
661
(3001019) Free T4 and TSH panel - Serum or Plasma
136
1383
0.98
0.05
2.1
1.8
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
26
273
0.95
0.05
2.3
1.5
u/ml
29.2
21.2
—
6
54
(40768441) Liver Pathology biopsy report
24
252
0.95
0.05
1.5
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
91
1.10
0.04
1.4
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
91
1.10
0.04
1.4
2.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
18
170
1.06
0.04
1.4
2.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
35
362
0.97
0.04
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
327
3246
1.01
0.04
1.6
1.6
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
20
190
1.05
0.04
1.2
1.1
u/l
31.0
22.8
0.33
14
137
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
20
190
1.05
0.04
1.2
1.1
u/l
83.0
75.7
0.18
15
142
(3015183) Erythrocyte sedimentation rate
13
121
1.07
0.03
1.1
1.2
—
—
—
0
0
(4281824)
47
458
1.03
0.03
1.2
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
51
522
0.98
0.03
1.1
1.2
u/l
34.3
36.4
0.07
45
441
(3006922) Hepatitis E virus Ab [Presence] in Serum
20
191
1.05
0.03
1.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
122
1.07
0.02
3.0
2.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
162
1.05
0.02
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
18
172
1.05
0.02
2.0
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
117
0.94
0.01
2.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
15
157
0.96
0.01
1.7
2.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
94
1.06
0.01
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
10
95
1.05
0.00
1.1
1.4
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
10
105
0.95
0.00
1.2
1.4
%
59.0
50.8
—
10
89
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
105
1.05
0.00
1.5
1.8
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
22
215
1.02
0.00
1.6
1.2
u/l
19.4
20.5
0.07
17
185
(4015189)
10
99
1.01
0.00
5.0
2.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
211
1.00
0.00
1.0
1.2
u/ml
0.0
0.9
—
5
102
(3000475) Leukocytes [#/volume] in Synovial fluid
83
829
1.00
0.00
2.1
1.6
e6/l
8777.4
11504.9
0.74
66
604
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
73
734
0.99
0.00
3.1
3.1
u/ml
498.3
810.2
0.22
62
669
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
18
176
1.02
0.00
1.1
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
166
1.02
0.00
1.7
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
18
176
1.02
0.00
1.1
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
10
96
1.04
0.00
1.4
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
166
1.02
0.00
1.7
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
16
156
1.03
0.00
1.3
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
157
1.02
0.00
1.0
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
22
223
0.99
0.00
1.6
1.2
u/l
84.7
78.9
0.20
16
197
(3041184) Isoniazid [Presence] in Urine
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
99
0.91
0.00
1.3
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
81
0.99
0.00
2.8
1.8
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
9
0.00
0.00
0.0
5.0
—
377.8
—
0
9
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
6
67
0.90
0.00
5.2
6.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
4146.0
—
0
5
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
9
96
0.94
0.00
1.8
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
153.9
—
0
5
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
16
160
1.00
0.00
3.6
4.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.6
—
2.1
—
0
7
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
5
56
0.89
0.00
1.6
2.6
ml/dl
15.5
14.5
—
5
50
(3004451) EKG impression Narrative
18
180
1.00
0.00
1.4
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
63
0.95
0.00
3.2
4.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
68
0.88
0.00
1.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
1.2
—
0
7
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
1205.0
—
0
6
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MENINGES and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MENINGES | 1.507 [1.37, 1.65] | < 0.001 |
| Birth year | 0.997 [0.99, 1.0] | 0.453 |
During the follow-up period (1.1.1998 — 31.12.2019), 3477 out of 13400 females with CD2_BENIGN_MENINGES died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MENINGES | 1.823 [1.6, 2.08] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 1506 out of 4504 males with CD2_BENIGN_MENINGES died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MENINGES.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.163% | 0.304% |
| 5 | 0.929% | 2.125% |
| 10 | 2.473% | 4.988% |
| 15 | 4.748% | 9.416% |
| 20 | 8.5% | 15.69% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MENINGES – Benign neoplasm of meninges
GWS hits: 8
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data